✦ LIBER ✦

Efficacy and safety of the once-daily human GLP-1 analogue, liraglutide, vs glibenclamide monotherapy in Japanese patients with type 2 diabetes

✍ Scribed by Seino, Y.; Rasmussen, M.F.; Nishida, T.; Kaku, K.

Book ID: 121664884
Publisher: Informa plc
Year: 2010
Tongue: English
Weight: 599 KB
Volume: 26
Category: Article
ISSN: 0300-7995
DOI: 10.1185/03007991003672551

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Liraglutide, a once-daily human GLP-1 an

Liraglutide, a once-daily human GLP-1 analogue, reduces systolic blood pressure within 2 weeks in patients with type 2 diabetes

✍ Fonseca, V.; Falahati, A.; Zychma, M.; Madsbad, S.; Plutzky, J. 📂 Article 📅 2009 🏛 Canadian Diabetes Association 🌐 English ⚖ 450 KB

Patient-reported rating of gastrointesti

Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutide

✍ M. Horowitz; T. Vilsbøll; M. Zdravkovic; M. Hammer; S. Madsbad 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB

The once-daily human GLP-1 analogue lira

The once-daily human GLP-1 analogue liraglutide impacts appetite and energy intake in patients with type 2 diabetes after short-term treatment

✍ Flint, A.; Kapitza, C.; Zdravkovic, M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB

Effect of the once-daily human GLP-1 ana

Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes

✍ Michael Horowitz; Anne Flint; Karen L. Jones; Charlotte Hindsberger; Mads F. Ras 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 525 KB

Significantly Better Glycemic Control an

Significantly Better Glycemic Control and Weight Reduction with Liraglutide, a Once-Daily Human GLP- 1 Analog, Compared With Glimepiride: All as Monotherapy In Type 2 Diabetes.

✍ Garber, A.; Henry, R.; Ratner, R.; Garcia-Hernandez, P.; Rodriquez Pattzi, H.M.; 📂 Article 📅 2008 🏛 Canadian Diabetes Association 🌐 English ⚖ 701 KB

The once-daily human glucagon-like pepti

The once-daily human glucagon-like peptide-1 analog, liraglutide, improves Î²-cell function in Japanese patients with type 2 diabetes

✍ Seino, Yutaka; Rasmussen, Mads Frederik; Clauson, Per; Kaku, Kohei 📂 Article 📅 2012 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 171 KB